FDA released the final guideline paper in March for first-in-human trial models that include both dosage escalation and various expansion cohorts to assess safety, anti-tumor

Research on genomic medicine is growing rapidly, which raises challenges concerning the design of clinical trials, regulatory channels, manufacturing processes, and price structures. Sandy Macrae,